Dr Ramzi Ajjan
Associate Professor & Consultant in Diabetes & Endocrinology,
The Leeds Teaching Hospitals NHS Trust
RA Ajjan (MD, FRCP, MMed.Sci, PhD) obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals Trust.
Dr Ajjan’s research work covers a spectrum of basic, translational and clinical studies with the common aim of reducing vascular complications in diabetes and reducing morbidity and mortality in this high-risk population.
His research group described three novel mechanisms for hypofibrinolysis in diabetes, with both hypo and hyperglycaemia having key roles. Moreover, Dr Ajjan has shown a close relationship between hypoglycaemia and adverse clinical outcome in patients with diabetes. Given the pathogenic effects of high and low blood glucose levels, he has been involved in a number of studies investigating the role of continuous glucose monitoring in optimising glycaemic control in diabetes.
Dr Ajjan’s research work has been published in peer reviewed journals and he has over 100 publications including original papers, reviews and book chapters. His clinical practice concentrates on complicated type 2 diabetes patients with established cardiovascular disease as well as young adults with diabetes. Dr Ajjan is the R&D lead for Diabetes/Endocrinology at Leeds Teaching Hospitals Trust and the regional clinical research network lead for endocrine and metabolic conditions.
He is also the lead for first year medical student teaching in Endocrinology and Diabetes at Leeds University and co-lead of the Atherothrombosis and Diabetes group within Leeds Institute for Cardiovascular and Metabolic Medicine.